VistaGen Therapeutics, Inc. (VTGN) Social Stream

VistaGen Therapeutics, Inc. (VTGN): $4.20

1.04 (-19.85%)

POWR Rating

Component Grades








Add VTGN to Watchlist
Sign Up

Industry: Biotech




#187 of 356

in industry

Featured Post From StockTwits About VTGN

$VTGN So I lived and died through what happened with SESN yesterday. Left my house for Michigan at 12 and by the time I stopped for a chalupa, my fiance tells me SENS is trading at 70 cents. While my loss is nothing compared to others, I'm confident that once the issues are identified, assuming they are fixable, it will eventually trade up again, albeit hesitantly.

Why I'm writing here is because I saw the message below regarding biopharms and Tute ownership. I've heard this platitude before. It intuitively seems correct, but is there data somewhere showing the correlation between Tute ownership and biopharm success? All I know is that we have almost 70% Tute ownership with major players owning most. Is it fair to assume also a correlation between major Tute ownership and insider knowledge or do most of you think the tutes are operating under the same data available to us (and I'm including Tute reports like the Baird report in data available to us retails).
veargogan, published August 14, 2021

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!